Manulife (Manufacturers Life Insurance)
EVLO

Manulife (Manufacturers Life Insurance)’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-824
Closed -$100 – 3218
2021
Q4 		$100 Buy
824
+300
+57% +$50.7K ﹤0.01% 3050
2021
Q3 		$74K Sell
524
-404
-44% -$80.1K ﹤0.01% 3114
2021
Q2 		$255K Buy
928
+233
+34% +$58.8K ﹤0.01% 2941
2021
Q1 		$149K Sell
695
-15
-2% -$4.15K ﹤0.01% 2984
2020
Q4 		$172K Buy
+710
New +$87.8K ﹤0.01% 2829

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s EVLO Position: Q1 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q1 2022, closing a stake of 824 shares — an estimated $100 sold.

Manulife (Manufacturers Life Insurance) first reported a position in EVLO in Q4 2020 and held it in 5 quarters. The position peaked at $255K in Q2 2021. 68 funds tracked by Wall St. Rank hold EVLO as of Q1 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 824 Evelo Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $100.
  • Manulife (Manufacturers Life Insurance) first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Manulife (Manufacturers Life Insurance)'s Evelo Biosciences, Inc. Common Stock position peaked at $255K in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q1 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.